The New India Assurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve The Company is holding a Board Meeting on 29th July 2025 for the purpose of declaration of Quarterly Results for the Quarter ended 30.06.2025.
Dear Sir/Madam, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Board of Directors of the Company, at its meeting held today, i.e., on 21st July 2025, has, inter alia, considered and approved the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th June 2025. The copies of said Unaudited Financial Results along with Limited Review Reports thereon of Statutory Auditors, Deloitte Haskins & Sells LLP, Chartered Accountants, are enclosed herewith.
Quess Corp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Board meeting intimation
Pursuant to the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, the company has published the unaudited financial results for the quarter ended 30th June, 2025.
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve the unaudited financial results for the quarter ended on June 30, 2025
Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2025.
